Yes. If left undiagnosed or inadequately managed, coagulation disorders can lead to serious complications. They generally present in one of two ways:
- Impaired blood clotting: Blood does not clot effectively, resulting in easy bruising, prolonged bleeding after injury or surgery, and in severe cases can lead to internal bleeding or intracranial hemorrhage.
- Excessive blood clotting: Abnormal clot formation within blood vessels can obstruct blood flow, leading to conditions such as deep vein thrombosis, pulmonary embolism, myocardial infarction, or ischemic stroke.
Many coagulation disorders remain asymptomatic during the early stages. Therefore, the Coagulation Function Panel is an effective approach for the early detection of coagulation abnormalities and thrombotic or bleeding risk, enabling timely clinical evaluation and appropriate management.
If you are receiving anticoagulant therapy (such as warfarin or heparin), this test should be performed only under the direction and close supervision of your treating physician to ensure safe and appropriate dose management.
Important: Do not undergo this test for the purpose of adjusting your medication dose on your own. Any changes to anticoagulant therapy should be made only under the guidance of your physician.
The risk of thrombus formation increases in the presence of one or more of the following risk factors:
- Advanced age, particularly 60 years and older.
- Prolonged immobility.
- Recent surgery, trauma, or major injury.
- Cancer or ongoing cancer treatment.
- Smoking.
- Obesity.
- Hypertension.
- Diabetes mellitus.
- Dyslipidemia.
- A personal or family history of thrombosis or inherited coagulation disorders.



